Select your location below to find contact information

Alternatively, if you are unable to report the side effect electronically you can email your local Novartis Drug Safety Responsible person. Please select the location you are reporting from the list below.

Contact information Afghanistan

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

Contact information Albania

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

Contact information Algeria

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information American Samoa

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Andorra

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Angola

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Anguilla

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Antigua and Barbuda

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Argentina

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Armenia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Aruba

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Australia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Austria

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Azerbaijan

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Bahamas

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Bahrain

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Bangladesh

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Barbados

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Belarus

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Belgium

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Belize

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Benin

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Bermuda

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Bhutan

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Bolivia, Plurinational state of

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Bosnia and Herzegovina

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Botswana

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Brazil

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Brunei Darussalam

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Bulgaria

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Burkina Faso

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Burundi

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Cambodia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Cameroon

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Canada

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Cape Verde

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Cayman Islands

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Central African Republic

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Chad

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Chile

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information China

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Christmas Island

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Cocos (Keeling) Islands

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Colombia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Comoros

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Congo

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Congo, The Democratic Republic Of

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Costa Rica

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Croatia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Cuba

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Curaçao

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Cyprus

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Czech Republic

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Côte D'ivoire

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Denmark

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Djibouti

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Dominica

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Dominican Republic

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Ecuador

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Egypt

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information El Salvador

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Equatorial Guinea

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Eritrea

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Estonia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Ethiopia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Fiji

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Finland

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities unless local legal regulations require to do so. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information France

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information French Guiana

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information French Polynesia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Gabon

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Gambia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Georgia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Germany

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Ghana

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Gibraltar

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Greece

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Greenland

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Grenada

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Guam

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Guatemala

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Guinea

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Guinea-Bissau

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Guyana

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Haiti

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Holy See (Vatican City State)

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Honduras

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Hong Kong

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Hungary

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Iceland

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information India

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Iraq

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Ireland

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Israel

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Italy

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Jamaica

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Jordan

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Kazakhstan

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Kenya

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Seychelles

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Sudan

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Sri Lanka

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Spain

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information South Africa

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Somalia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Slovenia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Slovakia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Singapore

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Sierra Leone

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Russian Federation

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Serbia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Senegal

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Saudi Arabia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

Patient Safety Department - Novartis Pharma AG - Saudi Arabia:

Toll free phone: 8001240078

Phone: +966112658100

Fax: +966112658107

Email: [email protected]

 

Contact information Sao Tome & Principe

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information San Marino

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Saint Vincent And The Grenadines

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Saint Martin (French Part)

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Saint Lucia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Saint Kitts And Nevis

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Saint Helena, Ascension And Tristan Da Cunha

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Rwanda

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Swaziland

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Suriname

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Uganda

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Sweden

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information United Kingdom

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Zambia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Qatar

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

ae.safetyreports[email protected]

 

Contact information Yemen

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Virgin Islands, U.S.

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Virgin Islands, British

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Viet Nam

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Venezuela, Bolivarian Republic Of

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Uzbekistan

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Uruguay

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information United States

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information United Arab Emirates

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Switzerland

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Ukraine

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Turkmenistan

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Turkey

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Tunisia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Trinidad And Tobago

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Togo

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Thailand

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Tanzania, United Republic Of

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Tajikistan

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Taiwan

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Syrian Arab Republic

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Romania

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Iran, Islamic Republic Of

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Puerto Rico

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Luxembourg

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Mauritius

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Mauritania

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Malta

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Mali

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Maldives

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Malaysia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Malawi

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected] 

 

Contact information Madagascar

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Macedonia, The Former Yugoslav Republic Of

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Macao

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Lithuania

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Moldova, Republic Of

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Liechtenstein

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Libya

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Liberia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Lesotho

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Lebanon

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Latvia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Kyrgyzstan

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Kuwait

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Korea, Republic of

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Indonesia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Mexico

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Monaco

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Portugal

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Nigeria

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Poland

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Philippines

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Peru

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Paraguay

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Papua New Guinea

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Panama

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Palestinian Territory, Occupied

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Pakistan

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Oman

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Norway

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Niger

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Mongolia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Nicaragua

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information New Zealand

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information New Caledonia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Netherlands

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Nepal

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Nauru

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Namibia

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Mozambique

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Morocco

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Montserrat

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Montenegro

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

Contact information Zimbabwe

When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:

  • Name of the drug:
    Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect.
  • The side effect associated with the drug:
    Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information.
  • Your name (optional):
    Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email.
  • Information about the person who experienced the side effect:
    Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).

[email protected]

 

1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.